Granisetron

Granisetron
Klinički podaci
Drugs.com	Monografija
Način primene	Intravenozno, oralno
Farmakokinetički podaci
Poluvreme eliminacije	4-6 h
Izlučivanje	48% renalno, 38% fekalno
Identifikatori
CAS broj	109889-09-0
ATC kod	A04AA02 (WHO)
PubChem	CID 3510
IUPHAR/BPS	2300
DrugBank	DB00889
ChemSpider	3390
KEGG	C07023
ChEMBL	CHEMBL519643
Hemijski podaci
Formula	C18H24N4O
Molarna masa	312,409
	SMILES CN1N=C(C(=O)NC2CC3CCCC(C2)N3C)C2=CC=CC=C12; ;
	InChI InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23) ; Key:MFWNKCLOYSRHCJ-UHFFFAOYSA-N ;
Fizički podaci
Tačka topljenja	219 °C (426 °F)

Granisetron je organsko jedinjenje, koje sadrži 18 atoma ugljenika i ima molekulsku masu od 312,409 Da.^[1]^[2]^[3]^[4]^[5]

Osobine[уреди | уреди извор]

Osobina	Vrednost
Broj akceptora vodonika	3
Broj donora vodonika	1
Broj rotacionih veza	2
Particioni koeficijent^[6] (ALogP)	2,4
Rastvorljivost^[7] (logS, log(mol/L))	-3,6
Polarna površina^[8] (PSA, Å²)	50,2

Reference[уреди | уреди извор]

^ Gan TJ: Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs. 2005;19(3):225-38. PMID 15740177
^ Tan M: Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting. Expert Opin Pharmacother. 2003 Sep;4(9):1563-71. PMID 12943486
^ Feyer P, Seegenschmiedt MH, Steingraeber M: Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies. Support Care Cancer. 2005 Sep;13(9):671-8. Epub 2005 Jul 26. PMID 16044252
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.